163 related articles for article (PubMed ID: 34507678)
21. IVF for fertility preservation in breast cancer patients--efficacy and safety issues.
Shapira M; Raanani H; Meirow D
J Assist Reprod Genet; 2015 Aug; 32(8):1171-8. PubMed ID: 26126877
[TBL] [Abstract][Full Text] [Related]
22. Gonadotropin-releasing hormone agonist ovulation trigger-beyond OHSS prevention.
Castillo JC; Haahr T; Martínez-Moya M; Humaidan P
Ups J Med Sci; 2020 May; 125(2):138-143. PubMed ID: 32208810
[TBL] [Abstract][Full Text] [Related]
23. Ovulation induction in polycystic ovary syndrome.
Tanbo T; Mellembakken J; Bjercke S; Ring E; Åbyholm T; Fedorcsak P
Acta Obstet Gynecol Scand; 2018 Oct; 97(10):1162-1167. PubMed ID: 29889977
[TBL] [Abstract][Full Text] [Related]
24. Aromatase inhibitors for ovulation and pregnancy in polycystic ovary syndrome.
Eckmann KR; Kockler DR
Ann Pharmacother; 2009 Jul; 43(7):1338-46. PubMed ID: 19584394
[TBL] [Abstract][Full Text] [Related]
25. Octreotide is not useful for clomiphene citrate resistance in patients with polycystic ovary syndrome but may reduce the likelihood of ovarian hyperstimulation syndrome.
Morris RS; Karande VC; Dudkiewicz A; Morris JL; Gleicher N
Fertil Steril; 1999 Mar; 71(3):452-6. PubMed ID: 10065781
[TBL] [Abstract][Full Text] [Related]
26. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
27. Reproductive endocrinology: revisiting ovulation induction in PCOS.
Fauser BC
Nat Rev Endocrinol; 2014 Dec; 10(12):704-5. PubMed ID: 25178733
[No Abstract] [Full Text] [Related]
28. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
[TBL] [Abstract][Full Text] [Related]
29. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.
Sousa M; Cunha M; Teixeira da Silva J; Oliveira C; Silva J; Viana P; Barros A
Reprod Biol Endocrinol; 2015 Jun; 13():66. PubMed ID: 26100393
[TBL] [Abstract][Full Text] [Related]
30. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
Talaulikar VS; Conway GS; Pimblett A; Davies MC
Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
[TBL] [Abstract][Full Text] [Related]
31. Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes.
Cela V; Obino MER; Alberga Y; Pinelli S; Sergiampietri C; Casarosa E; Simi G; Papini F; Artini PG
Gynecol Endocrinol; 2018 Jun; 34(6):518-523. PubMed ID: 29271274
[TBL] [Abstract][Full Text] [Related]
32. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
Fatemi HM; Garcia-Velasco J
Fertil Steril; 2015 Apr; 103(4):870-3. PubMed ID: 25724740
[TBL] [Abstract][Full Text] [Related]
33. Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis.
Zhao J; Xu B; Huang X; Yan Y; Li Y
Reprod Health; 2020 Nov; 17(1):181. PubMed ID: 33218353
[TBL] [Abstract][Full Text] [Related]
34. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
35. ALGORITHM OF OVULATION INDUCTION IN PATIENTS WITH POLYCISTIC OVARY SYNDROME.
Bjelica A; Bjelanović J; Milić N; Mladenović Segedi L; Ilić Đ; Dimitrijević J
Med Pregl; 2016; 69(1-2):25-30. PubMed ID: 27498530
[TBL] [Abstract][Full Text] [Related]
36. Controlled ovarian hyperstimulation in women with polycystic ovarian syndrome with or without intrauterine insemination.
Wiser A; Shalom-Paz E; Reinblatt SL; Holzer H; Tulandi T
Gynecol Endocrinol; 2012 Jul; 28(7):502-4. PubMed ID: 22122754
[TBL] [Abstract][Full Text] [Related]
37. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
38. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
[TBL] [Abstract][Full Text] [Related]
39. Late-onset ovarian hyperstimulation syndrome developing during ovarian stimulation in an ectopic pregnancy: a case report.
Huang H; Takai Y; Samejima K; Narita T; Ichinose S; Itaya Y; Ono Y; Matsunaga S; Saitoh M; Baba K; Hayashi N; Seki H
J Med Case Rep; 2020 Jul; 14(1):110. PubMed ID: 32684165
[TBL] [Abstract][Full Text] [Related]
40. Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.
Keskin U; Ercan CM; Yilmaz A; Babacan A; Korkmaz C; Duru NK; Ergun A
J Pak Med Assoc; 2014 Jul; 64(7):830-2. PubMed ID: 25255597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
